Exact Sciences (EXAS) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
Meeting called to order by the CEO and Chairman, with roles assigned for voting inspector and secretary.
Virtual format adopted to increase access and participation; shareholders could submit questions and vote online.
April 15, 2024, set as the record date; notice and proxy materials distributed starting April 25, 2024.
Quorum confirmed, allowing business to proceed.
Agenda included election of three directors, ratification of the auditor, and advisory approval of executive compensation.
Board and executive committee updates
Three individuals nominated for Class III director positions: Michael Barber, Paul Clancy, and Daniel Levangie.
Shareholder proposals
Proposals included election of directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory approval of executive compensation.
Board recommended a vote in favor of all proposals.
Latest events from Exact Sciences
- Merger and adjournment proposals approved; compensation proposal not approved.EXAS
AGM 20269 Jul 2026 - Growth driven by innovation, digital integration, and organizational agility, with guidance reaffirmed.EXAS
The 44th Annual William Blair Growth Stock Conference8 Jul 2026 - Multi-cancer early detection could cut late-stage cancer by 40% and mortality by 18%.EXAS
7th Annual Healthcare Symposium8 Jul 2026 - International expansion accelerates with new products, offices, and integration with Abbott.EXAS
Proxy Filing17 Feb 2026 - Record revenue, improved cash flow, and major merger plans mark a transformative year.EXAS
Q4 202513 Feb 2026 - Merger with Abbott at $105 per share prompts supplemental disclosures and litigation response.EXAS
Proxy Filing10 Feb 2026 - Q2 revenue up 12% to $699M; record test volumes and raised EBITDA guidance.EXAS
Q2 20242 Feb 2026 - Cologuard Plus, automation, and global expansion fuel strong growth and margin gains.EXAS
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Cologuard Plus and a robust pipeline position the company for sustained growth and market leadership.EXAS
Jefferies Global Healthcare Conference1 Feb 2026